SEC Form DFiling only, no announcement found
Jupiter Neurosciences, based in Palm Beach Gardens, FL, reported $774,787 sold in a private offering of equity, with the first sale on August 20, 2026, in a Form D filed with the SEC on September 4, 2026. The filing says 1 investor has already invested.
Legal name on the filing: JUPITER NEUROSCIENCES, INC.. Formerly Jupiter Orphan Therapeutics, Inc..
| Amount sold | $774,787Basis: Form D total amount sold, as of the filing of September 4, 2026. Not the announced round size. |
|---|---|
| Total offering | $774,787The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $0 |
| Securities offered | Equity |
| Exemption claimed | Rule 506(b) |
| Date of first sale | August 20, 2026 |
| Investors already invested | 1 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Other Health Care |
| Principal place of business | Palm Beach Gardens, FL |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 1679628 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Christer Rosen | Executive Officer, DirectorChief Executive Officer | None linked |
| Alison Silva | Executive Officer, DirectorChief Operating Officer | None linked |
| Saleem Elmasri | Executive OfficerChief Financial Officer | None linked |
| Marshall Hayward | Executive Officer, DirectorChief Scientific Officer | None linked |
| Alexander Rosen | Executive OfficerChief Administrative Officer | None linked |
| Nicholas Hemmerly | Director | None linked |
| Holger Weiss | Director | None linked |
| Andrew Cutler | Director | None linked |
| Tomas Philipson | Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Sep 4, 2026 | D (original) | $774,787 | $774,787 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
From the issuer's EDGAR filing history. Amounts are shown for filings in our warehouse, which holds operating-company filings from July 16, 2026.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Jupiter Neurosciences: SEC Form D deal record", https://vcbeast.com/deals/jupiter-neurosciences-form-d-2026-08-20. Source: SEC EDGAR, accession 0001493152-26-041606.